Homepage - Intelligent Health

Intelligent Health 

The world’s leading AI in medicine summit series

07-08 September 2022

The Congress Center Basel, Switzerland & Online

Connecting 200,000 clinicians, technologists and C-suite executives to create a future where AI will revolutionise health

Book tickets

Partner with us

Download programme

Download event brochure

 

Produced by

Ticket prices will increase in

Days

Hours

Min

Sec

200,000+
community members

120+
speakers

160+
countries

5
tracks

WE’RE BACK TO SWITZERLAND! And we’re Bolder, Braver, Bigger!

Intelligent health will return to Basel, Switzerland, on the 7th and 8th September 2022 to bring together the global AI and health communities to advance discussions on how to apply AI and drive technological collaboration in healthcare.

So save the date, register your tickets, claim your exhibitor booths, and get ready for the perfect mix of inspiration, collaboration, business and fun. Because we are Inspired Minds – we make innovation with impact happen.

What’s Intelligent Health?

C-level executives, clinicians, hospital heads and scientists from pharma, biotech, medtech, health provisions, tech, startups and investment companies from every corner of the globe will join at the exclusive physical summit and online via our global platform.

This year, we’ve tossed away the rule book and re-designed the summit to focus on what matters the most. Our CPD-accredited large-scale global summit brings together the global AI and health communities to advance discussions on how to apply AI and drive technological collaboration in healthcare, by connecting clinicians, patients and decision makers in healthcare settings with technologists. Be ready to think like a physician and code like a developer!

Startups Showcase 

Celebrating industry newcomers set to

revolutionise healthcare as we know it!


Application Deadline Friday 12th August 2022

Finalists announced Tuesday 16th August 2022

Complete your Application Form

HEADLINE PARTNER

The Novartis Foundation strives for a transformational and sustainable impact on the health of low-income populations. In recent years, we reached over 30 million people with innovative healthcare delivery models. By measuring individual health outcomes and population health impact, we generate evidence to translate the successful models into health policy. In 2019, the Novartis Foundation sharpened its focus to concentrate fully on how data, digital technology and AI can improve population health around the world, and transform health and care systems from being reactive to becoming proactive and even predictive.

novartisfoundation.org

@NovartisFDN

Who’s Coming?

Hospitals, Health Practices, Big Tech, Health Tech AI, Startups, Pharma, Biotech and Medical Device, Health insurers, Academics, Investors, Associations

CEO, CTO, CMIO, CCIO, CIO, CDIO, CMO, CDO, CSO, Directorate Digital Lead​​

VP, Director, Head of, Managing Director, Head of  Technology/Innovation/ AI/ Machine Learning/ Computer Vision/ Cognitive Computing/Data Science/ Data Analytics/ Data Strategy

Clinicians and healthcare professionals:

Heads of, Directors, Consultants in Oncology, Radiology, Pathology, Medicinal Chemistry, Cell Therapy, Rare diseases, Biosimilars, Imaging, Diabetes, Opthalmology, Cardiology, Diagnostics

View Attendees

 

Meet our industry pioneers –

all of our AI in medicine Brains

 

DR. ANN AERTS
Head of Novartis Foundation
Novartis Foundation
 
DR. ANN AERTS
Head of Novartis Foundation
Novartis Foundation
 
DR. ERIC TOPOL
Executive Vice-President | Scripps Research Institute
Director & Founder | Scripps Research Translational Institute
DR. ERIC TOPOL
Executive Vice-President | Scripps Research Institute
Director & Founder | Scripps Research Translational Institute

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research. As a researcher, he has published over 1,200 peer-reviewed articles, with more than 310,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207 million grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has over 440,000 followers on Twitter (@EricTopol) where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published 3 bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.

LAURA MATZ
Chief Science & Technology Office
Merck KGaA
LAURA MATZ
Chief Science & Technology Office
Merck KGaA

Dr. Laura Matz is the Chief Science and Technology for Merck, driving innovation and digitalization in Merck across the 3 business sectors, Life Sciences, Healthcare and Electronics.    Serving as an executive vice-president within Merck, she is responsible for the corporate innovation teams including the digital office and new digital business models.  She possesses 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses. 

Prior to becoming the CSTO, she was a senior vice-president within EMD Electronics (previously Versum Materials and Air Products Electronics division). She has always been a key contributor to the growth in semiconductor materials, driving for a strong R&D presence to enable business growth.  

Laura is a strong advocate for science and engineering in young talent.  She has collaborated with ASU over the past 5 years to build a strong pipeline of interns.  In 2020, Laura joined the AICHE (American Institute of Chemical Engineers) ILI board (Institute for Learning and Innovation) which serves as a conduit for advancing chemical engineering talent for the U.S.    Given that artificial intelligence and machine learning are enablers for the continued growth in the semiconductor industry, she is a member of the SEMI Smart Manufacturing board as well as the local AZ SEMI board. 

Laura has a PhD in analytical chemistry from Washington State University and undergraduate degree from Indiana University of Pennsylvania.  When she is not working, Laura enjoys watching soccer games and running in the beautiful Arizona weather.

DR. GREG MOORE
CVP
Microsoft Health & Life Sciences
             
DR. GREG MOORE
CVP
Microsoft Health & Life Sciences
             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

CAROLYN STARRETT
CEO
Flatiron Health
CAROLYN STARRETT
CEO
Flatiron Health

Carolyn Starrett is CEO of Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.

Almost everything known today about what works for patients with cancer comes from the relative few who enroll in randomized controlled trials. Flatiron uses clinical and data science to improve lives by learning from the experience of every cancer patient. Insights from Flatiron’s U.S-derived real-world data and analyses support meaningful learnings relevant to a global cancer population, and have helped expand treatment alternatives for people with gastric, colorectal, esophageal, breast, and head and neck cancer. Through three international subsidiaries, Flatiron now also works to improve treatments and outcomes for cancer patients in Japan, Germany and the United Kingdom.

Carolyn became Flatiron CEO in April, succeeding the company’s co-founders and bringing a deep understanding of the challenges facing those on the cancer frontlines from her years leading the company’s community oncology business. Prior to joining Flatiron in 2016, Carolyn held senior strategy, product and operations roles at data and technology companies, and worked with healthcare and technology companies as a principal with Boston Consulting Group. Carolyn holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor’s degree from Brown University.

DR. LE LU (TIGER)
Senior Director
Alibaba DAMO Academy PhD
DR. LE LU (TIGER)
Senior Director
Alibaba DAMO Academy PhD

Le Lu received a Computer Science PhD in 2007 from Johns Hopkins University. During his first six years at Siemens, he made significant contributions to the company’s CT colonography and Lung CAD product lines. 

From 2013 to 2017, Dr. Lu served as a staff scientist in the Radiology and Imaging Sciences Department of the National Institutes of Health Clinical Center. He then went on to found Nvidia’s medical image analysis group and he held the position of senior research manager until June 2018. From 2018 to 2021, he was the Executive Director at PAII Inc., Bethesda Research lab, Maryland, USA which has become one of the leading industrial research labs in medical imaging. 

He is currently the global head of Medical AI R&D for Alibaba group. He was the main technical leader for two of the most-impactful public radiology image dataset releases (NIH ChestXray14, NIH DeepLesion 2018). 

He won NIH Clinical Center Director Award in 2017, NIH Mentor of the year award in 2015, and won numerous best paper awards in recent MICCAI and RSNA technical and clinical conferences from 2016 to 2021 (over 11600 citations). In 2021, He was elected into IEEE Fellow class cited for his contribution to machine learning for cancer detection and diagnosis, and MICCAI society board member (MICCAI-Industry Workgroup Chair). He is currently an Associate Editor for IEEE Trans. Pattern Analysis and Machine Intelligence and IEEE Signal Processing Letters. He has published more than 200 peer-reviewed articles and leading conference papers in Nature Communications, Clinical Cancer Research, IEEE TMI, MedIA, etc. He is the (co-)inventor of 69 USPTO/PCT patents (granted or pending).

JEROEN TAS
Strategic Business Development
Philips
JEROEN TAS
Strategic Business Development
Philips

Jeroen Tas is responsible for Strategic Business Development at Philips and former Chief Innovation & Strategy Officer at Philips. He has more than 35 years of global experience as an entrepreneur and executive in the healthcare, information technology and financial services industries.

Jeroen is closely involved with the company’s strategy, platforms, ventures and emerging businesses. In his current position in Strategic Business Development, he plays a central role in coaching digital business ventures and leadership and is involved in strategic projects to create new models of people-centric healthcare. He leverages emerging technologies such as artificial intelligence, robotics and the Internet of Things to reinforce the company’s health propositions aimed at supporting consumers, care professionals and health systems with personalized, connected health solutions. 

Jeroen’s stance is echoed in Philips’ commitment to touch the lives of billions and improve better health outcomes at lower cost: from healthy living and prevention to diagnosis, treatment and home care. 

A respected thought leader, Jeroen was responsible for turning around Philips’ healthcare IT business and has been instrumental in establishing HealthSuite as the new open industry standard for the ‘Healthcare Internet of Things’ Cloud platform.

Jeroen joined Philips in 2011, leading IT worldwide as Group Chief Information Officer (CIO). In 2014 he became CEO of Philips Healthcare, Informatics Solutions & Services, overseeing digital health and clinical informatics. From 2016, Jeroen led the company’s Connected Care and Informatics businesses, demonstrating a passion to create new models of people-centric healthcare, based on the power of information technology.

Before joining Philips, Jeroen co-founded and served as President, COO and Vice-Chairman of the board for MphasiS, an IT and Business Process Outsourcing company, which was acquired by HP in 2006. Prior to MphasiS, he was the head of Transaction Technology, Inc., Citigroup’s tech lab, responsible for the innovation and development of the bank’s customer-facing systems, including Internet banking and self-service devices. From 2007-8, he was Vice President and General Manager at EDS, responsible for the company’s global competency centers.

NATASHA SUNDERJI
Global Health Lead at Accenture Development Partnerships 
Accenture
NATASHA SUNDERJI
Global Health Lead at Accenture Development Partnerships 
Accenture

Natasha Sunderji is the Global Health Lead at Accenture Development Partnerships – Accenture’s social impact business. Natasha leads multi-disciplinary teams as they help pharma, medtech, NGOs, donors, and multilateral agencies reshape the future of global health, and redefine their roles in it. She has 15+ years of experience advising organizations on growth strategy, business model design, digital health, and cross sector partnerships. In 2020, Natasha was named as one of the top 50 innovators in the WSAI community.

PROFESSOR SIR NIGEL SHADBOLT
Professor of Computing Science | University of Oxford
Chairman and Co-Founder | Open Data Institute
PROFESSOR SIR NIGEL SHADBOLT
Professor of Computing Science | University of Oxford
Chairman and Co-Founder | Open Data Institute

Sir Nigel Shadbolt is Principal of Jesus College and Professor of Computing Science at the University of Oxford, where he has centred his research in human centred AI in a wide range of applications.  Most recently he was asked to lead the setting up of the Oxford Institute of Ethics in AI.  He is also the Chairman and Co-Founder of the Open Data Institute (ODI).  Since 2009, Sir Nigel has helped transform public access to Government information.

In 2010, he joined the UK government’s Public Sector Transparency Board – overseeing Open Data releases across the public sector.  He was knighted in 2013 for ‘services to science and engineering’. 

With over 500 publications, he has researched and published on topics ranging from cognitive psychology to computational neuroscience, Artificial Intelligence to the Semantic Web.  In 2018 he published The Digital Ape: how to live (in peace) with smart machines, described as a ‘landmark book’.

He is a Fellow of The Royal Society, the Royal Academy of Engineering and the British Computer Society.

DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 
DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 

Dr Sujoy Kar is the Chief Medical Information Officer & Vice President at Apollo Hospitals. Previously, he was the Director Medical Services at Apollo Gleneagles Hospitals Kolkata. He obtained his post graduate MD in Clinical Microbiology & Infectious Diseases and is an alumnus of MIT Sloan School of Management. He is a Certified Six Sigma Master Black Belt (Indian Statistical Institute) and member of professional organisations like ACHE, VRARA (Member – Healthcare Sub Committee), CHIME, Harvard Square (LE), ICMR – CIBioD (Member Task Force) and World Economic Forum – Chatbot & AI in Healthcare.

Dr Sujoy is currently associated with IIT Kharagpur & IIM Calcutta as Adjunct Faculty for Healthcare Analytics and Management. He has led teams in multiple award winning Patient Safety & Process Improvement projects. His current and ongoing research interests are in adoption of Artificial Intelligence & Blockchain Technology in Healthcare, Time Driven Activity Based Costing, Living Labs, Digital Health Platforms and Design Thinking in Healthcare.

DR. JUNAID BAJWA
Chief Medical Scientist
Microsoft
DR. JUNAID BAJWA
Chief Medical Scientist
Microsoft

Dr. Junaid is a practicing physician in the NHS and is also the Chief Medical Scientist at Microsoft Research. He also serves as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy. Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health. Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer,and policy maker within the UK, where he specialised in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe.

DR. MATTHEW LUNGREN

Co-Director
Center for Artificial Intelligence in Medicine and Imaging
Assistant Professor of Radiology
Stanford University School of Medicine

DR. MATTHEW LUNGREN

Co-Director
Center for Artificial Intelligence in Medicine and Imaging
Assistant Professor of Radiology
Stanford University School of Medicine
PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
DR OLIVER MORGAN
Director of Health Emergency and Risk Assessment - WHO Health Emergencies Program
World Health Organization
DR OLIVER MORGAN
Director of Health Emergency and Risk Assessment - WHO Health Emergencies Program
World Health Organization

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program.  From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone). From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic.  Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala.  

Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts.  Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries.  Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

PIETER JEEKEL
Chairman
Netherlands AI Coalition for Well-being & Healthcare
PIETER JEEKEL
Chairman
Netherlands AI Coalition for Well-being & Healthcare

Pieter Jeekel is chairman of the Netherlands AI Coalition for Well-being & Healthcare and director and founder of Evodoc and The Social Health Company. Pieter has a background as an eHealth entrepreneur and leader of nationwide healthcare reform programs.

ELEONORA HARWICH
Head of Collaborations 
NHS AI Lab at NHSX
ELEONORA HARWICH
Head of Collaborations 
NHS AI Lab at NHSX

Eleonora is Head of Collaborations of NHSX’s AI Lab. Her work focuses on communicating and engaging with health and care professionals, the public and industry to support and share the work of the NHS AI Lab and the potential of AI. She has co-authored papers on AI in the NHS, the value of healthcare data, commercial models in healthcare and the regulation of data-driven technologies. She is a member of the British Standards Institution’s Committee on Artificial Intelligence and the London Hub Lead of One HealthTech, a grassroots community which seeks to promote diversity in healthtech.

PROFESSOR DR MAX WELLING
Distinguished Scientist | Microsoft Research
Research Chair in Machine Learning | University of Amsterdam
PROFESSOR DR MAX WELLING
Distinguished Scientist | Microsoft Research
Research Chair in Machine Learning | University of Amsterdam

Prof. Dr. Max Welling is a research chair in Machine Learning at the University of Amsterdam and a VP Technologies at Qualcomm. He has a secondary appointment as a fellow at the Canadian Institute for Advanced Research (CIFAR). Max Welling has served as associate editor in chief of IEEE TPAMI from 2011-2015. He serves on the board of the Neurips foundation since 2015 and has been program chair and general chair of Neurips in 2013 and 2014 respectively. He was also program chair of AISTATS in 2009 and ECCV in 2016 and general chair of MIDL 2018. He is a founding board member of ELLIS. Max Welling is recipient of the ECCV Koenderink Prize in 2010. He directs the Amsterdam Machine Learning Lab (AMLAB) and co-directs the Qualcomm-UvA deep learning lab (QUVA) and the Bosch-UvA Deep Learning lab (DELTA). He is a fellow and founding board member of the European Lab for learning and Intelligent systems (ELLIS).

Don’t miss a thing!

Subscribe to the Intelligent Health mailing list to be the first to receive the latest event news, event programme, speaker lineup, promotions and discounted tickets.

Subscribe

“Energizing, uplifting and educational! The best of AI without the hype – truly about how AI can impact and improve the health of all people, across diverse geographies, diseases and resources."

Vice President, Strategic Data and Digital, US Oncology

Novartis Foundation

"Unlike any I've attended before - It was a unique combination of science and glamour - all presented in a format that kept my full attention."

Co-Founder and Chief Science Officer

Lapetus

"A pioneering event that gets health care providers, hospitals, data scientists, startups & corporates together to talk about challenges and disruptive changes and how to get them realised. Great energy and great insights."

Consultant Cardiac Anaesthetist, AMC & Founder

Healthplus.ai

Sponsor or exhibit

Raise your company’s profile and get in front of the brightest healthcare AI brains, spanning the whole global ecosystem of pharmaceutical, biotech, medtech, clinicians and healthcare providers, health tech companies, insurers, academics and investors.

A good way to work out what will give you the most cost-effective impact is to talk to us.

CONTACT US

Get started today, download the sales pack

DOWNLOAD SALES PACK

Our Intelligent Health AI global summit series

 

2023 dates TBC

London, United Kingdom

In partnership with our Innovation Partners NHS AI Lab – NHS Transformative Directorate, NIHR, The Health Innovation Network, AHSN Network and DigitalHealth. London, we will once again bring together the UK health community to focus on what matters the most, to break down the barriers between tech and healthcare to #SaveLivesWithAI.

london.intelligenthealth.ai

07-08 September 2022

Basel, Switzerland

Intelligent Health AI will once again bring together the global AI and health community next September to advance discussions on how AI can be used to prevent and solve some of the world’s greatest healthcare problems, and improve the health of the human race. tech and healthcare to #SaveLivesWithAI. to break down the barriers between tech and healthcare to

intelligenthealth.ai

 

Thanks to our Supporters

Advisors

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health